Patents by Inventor Laia Sole Feu

Laia Sole Feu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aminoindazole derivatives as sodium channel inhibitors
    Patent number: 10173985
    Abstract: The present invention relates to novel aminoindazolyl derivative compounds of Formula (I), the use of said compounds in treating diseases mediated by modulation of voltage-gated sodium channels in particular Nav 1.7, to compositions containing said derivatives and processes for their preparation.
    Type: Grant
    Filed: March 22, 2016
    Date of Patent: January 8, 2019
    Assignee: Almirall, S.A.
    Inventors: Laia Sole Feu, Silvia Fonquerna Pou
  • AMINOINDAZOLE DERIVATIVES AS SODIUM CHANNEL INHIBITORS
    Publication number: 20180244626
    Abstract: The present invention relates to novel aminoindazolyl derivative compounds of Formula (I), the use of said compounds in treating diseases mediated by modulation of voltage-gated sodium channels in particular Nav 1.
    Type: Application
    Filed: March 22, 2016
    Publication date: August 30, 2018
    Inventors: Laia SOLE FEU, Silvia FONQUERNA POU
  • Cyclohexyl and quinuclidinyl carbamate derivatives having ?2 adrenergic agonist and M3 muscarinic antagonist activity
    Patent number: 9518050
    Abstract: The present invention relates to novel compounds having ?2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
    Type: Grant
    Filed: December 17, 2013
    Date of Patent: December 13, 2016
    Assignee: Almirall, S.A.
    Inventors: Laia Sole Feu, Ines Carranco Moruno, Jose Aiguade Bosch, Carlos Puig Duran, Silvia Fonquerna Pou
  • NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY
    Publication number: 20150329535
    Abstract: The present invention relates to novel compounds having ?2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
    Type: Application
    Filed: December 17, 2013
    Publication date: November 19, 2015
    Inventors: Laia SOLE FEU, Ines CARRANCO MORUNO, Jose AIGUADE BOSCH, Carlos PUIG DURAN, Silvia FONQUERNA POU
  • Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the ?2 adrenergic receptors
    Patent number: 8178679
    Abstract: The present disclosure relates to 4-(2-amino-1-hydroxyethyl)phenol derivatives of formula (I) as well as pharmaceutical compositions comprising them, and their use in therapy as agonists of the ?2 adrenergic receptor.
    Type: Grant
    Filed: November 10, 2008
    Date of Patent: May 15, 2012
    Assignee: Almirall, S.A.
    Inventors: Victor Giulio Matassa, Carlos Puig Duran, Maria Prat Quiñones, Laia Sole Feu, Oriol Llera Soldevila